A Study to Investigate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7497372 in Participants With Diabetic Macular Edema (DME)
NCT06847854
·
clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
151
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetic Macular Edema
Interventions
DRUG:
RO7497372
Sponsor
Genentech, Inc.